# FDA clears ReWalk 7, the seventh-generation ReWalk personal exoskeleton

Canonical page: https://technooptimist.io/stories/fda-clears-rewalk-7-the-seventh-generation-rewalk-personal-exoskeleton-3a46c957
Date: 13 Mar 2025
About: [Lifeward](https://technooptimist.io/companies/lifeward.md) · [ReWalk 7](https://technooptimist.io/robotics/rewalk-7.md)
Original source: https://golifeward.com/?p=3127

Lifeward received FDA 510(k) clearance for ReWalk 7, the seventh generation of its personal exoskeleton for people with spinal cord injury. The clearance builds on the 2023 approval of ReWalk 6.0 for stairs and curbs and the 2024 Medicare payment decision. CEO Larry Jasinski called it a major milestone for the company and the industry.

## Key facts

- 510(k) clearance announced March 13, 2025, for people with spinal cord injury.
- ReWalk was the first exoskeleton the FDA cleared for spinal cord injury, in 2014.
- US sales were set to begin as soon as the product was available (launched April 15, 2025).

---

The Techno Optimist tracks every frontier of technology, program by program: https://technooptimist.io/ (a Markdown version of any page: add .md to its URL; site map for agents: https://technooptimist.io/llms.txt).
Data API (JSON, realtime stream): https://technooptimist.io/developers. People read 5 pages free, then Reader $10/month; these Markdown pages are open to agents.